Literature DB >> 19186334

The incidence rate of seizures in relation to BMI in UK adults.

Shujun Gao1, Juhaeri Juhaeri, Wanju S Dai.   

Abstract

A retrospective cohort study using the data from The Health Improvement Network (THIN) database in the United Kingdom was conducted to examine the incidence rates of seizures across different BMI levels in the adult population aged > or = 18 years. Poisson regression was used to examine the relationship between BMI and seizures. The overall incidence rate of seizures was found to be 31.2 cases per 100,000 person-years. The incidence rate of seizures (cases per 100,000 person-years) in obese patients (BMI > or = 30 kg/m2) was 34.8 (95% confidence interval (CI), 23.1, 46.4), comparable to that in patients with normal weight (BMI between 18.5 and 24.9 kg/m2) (35.8, 95% CI (26.6, 44.9)). In contrast, underweight patients (< 18.5 kg/m2) or extremely obese (> or = 40 kg/m2) patients tended to have higher incidence rates than those with normal weight. After adjustment for age, gender, and smoking status, compared to patients with normal weight, those who were underweight or extremely obese had a rate ratio (RR) for seizures of 1.6 (95% CI (0.7, 3.8)) and 1.7 (95% CI (0.7, 3.9)), respectively. To date, we have not found any study that examines the associations between BMI or obesity and seizures. In this study, the incidence rates of seizures in the extremely obese and underweight patients tended to be higher than that in the normal-weight patients.

Entities:  

Mesh:

Year:  2008        PMID: 19186334     DOI: 10.1038/oby.2008.310

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  2 in total

1.  Lifestyle factors, psychiatric and neurologic comorbidities, and drug use associated with incident seizures among adult patients with depression: a population-based nested case-control study.

Authors:  Marlene Bloechliger; Alessandro Ceschi; Stephan Rüegg; Susan Sara Jick; Christoph Rudolf Meier; Michael Bodmer
Journal:  Eur J Epidemiol       Date:  2016-05-04       Impact factor: 8.082

2.  Obesity and overweight as CAE comorbidities and differential drug response modifiers.

Authors:  Ravindra Arya; Catherine W Gillespie; Avital Cnaan; Mahima Devarajan; Peggy Clark; Shlomo Shinnar; Alexander A Vinks; Kana Mizuno; Tracy A Glauser
Journal:  Neurology       Date:  2016-03-30       Impact factor: 9.910

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.